{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:50:06Z","timestamp":1787986206828,"version":"build-2784847793"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.leukres.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T21:05:39Z","timestamp":1442005539000},"page":"1137-1145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Smoking as a contributing factor for development of polycythemia vera and related neoplasms"],"prefix":"10.1016","volume":"39","author":[{"given":"Hans Carl","family":"Hasselbalch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.09.002_bib0005","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk Res."},{"key":"10.1016\/j.leukres.2015.09.002_bib0015","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain of function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2015.09.002_bib0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2015.09.002_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2015.09.002_bib0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2015.09.002_bib0040","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","article-title":"New mutations and pathogenesis of myeloproliferative neoplasms","volume":"188","author":"Vainchenker","year":"2011","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.leukres.2015.09.002_bib0045","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.leukres.2015.09.002_bib0050","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.leukres.2015.09.002_bib0055","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2014-03-530865","article-title":"From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms","volume":"123","author":"Cazzola","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.002_bib0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s000180050394","article-title":"The role of STATs in proliferation, differentiation, and apoptosis","volume":"55","author":"Mui","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.leukres.2015.09.002_bib0065","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK\u2013STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2015.09.002_bib0070","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bcp.2011.12.024","article-title":"The many faces of Janus kinase","volume":"83","author":"Seavey","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.leukres.2015.09.002_bib0075","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2015.09.002_bib0080","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","article-title":"The role of cytokines in the initiation and progression of myelofibrosis","volume":"24","author":"Hasselbalch","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.leukres.2015.09.002_bib0090","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1189\/jlb.1202626","article-title":"Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB","volume":"74","author":"Iho","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.leukres.2015.09.002_bib0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.CIR.72.5.971","article-title":"The relationship of white cell count, platelet count, and hematocrit to cigarette smoking in adolescents: the Oslo Youth Study","volume":"72","author":"Tell","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.leukres.2015.09.002_bib0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.leukres.2015.09.002_bib0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.leukres.2015.09.002_bib0110","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1161\/CIRCULATIONAHA.109.918417","article-title":"Inflammation in peripheral arterial disease","volume":"122","author":"Brevetti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.leukres.2015.09.002_bib0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/heartjnl-2013-304082","article-title":"Meta-analysis of the association between smoking and peripheral arterial disease","volume":"100","author":"Lu","year":"2014","journal-title":"Heart"},{"issue":"34","key":"10.1016\/j.leukres.2015.09.002_bib0120","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.2174\/092986732134141015161539","article-title":"Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches","volume":"21","author":"Siasos","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.leukres.2015.09.002_bib0125","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1038\/sj.onc.1205803","article-title":"Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers","volume":"21","author":"Pfeifer","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2015.09.002_bib0130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1378\/chest.06-2179","article-title":"Systemic effects of smoking","volume":"131","author":"Yanbaeva","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.leukres.2015.09.002_bib0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.STR.3.4.409","article-title":"Hemoglobin and the risk of cerebral infarction: the Framingham study","volume":"3","author":"Kannel","year":"1972","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","article-title":"Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors","volume":"83","author":"Watson","year":"1993","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2015.09.002_bib0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/000331979804900609","article-title":"Cerebral vascular accidents in young patients with essential thrombocythemia: relation with other known cardiovascular risk factors","volume":"49","author":"Randi","year":"1998","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002770000244","article-title":"The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia","volume":"80","author":"Jantunen","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2015.09.002_bib0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2015.09.002_bib0160","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2015.09.002_bib0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"United Kingdom medical research council primary thrombocythemia 1 study. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.leukres.2015.09.002_bib0175","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"European collaboration on low-dose aspirin in polycythemia vera (ECLAP). Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.002_bib0180","first-page":"874146","article-title":"Gender and vascular complications in the JAK2 V617F-positive myeloproliferative neoplasms","author":"Stein","year":"2011","journal-title":"Thrombosis"},{"issue":"6","key":"10.1016\/j.leukres.2015.09.002_bib0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"European LeukemiaNet. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajh.23895","article-title":"Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management","volume":"90","author":"Tefferi","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2015.09.002_bib0195","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/ajh.23744","article-title":"The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies","volume":"89","author":"Fircanis","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.leukres.2015.09.002_bib0200","doi-asserted-by":"crossref","first-page":"e67537","DOI":"10.1371\/journal.pone.0067537","article-title":"Meta-analysis of the relationship between cigarette smoking and incidence of myelodysplastic syndromes","volume":"8","author":"Tong","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajh.22180","article-title":"Janus kinase V617F mutation in cigarette smokers","volume":"87","author":"Weinberg","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2015.09.002_bib0215","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/bjc.2012.333","article-title":"Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study","volume":"107","author":"Kroll","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.leukres.2015.09.002_bib0220","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.28492","article-title":"Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa women's health study cohort","volume":"134","author":"Leal","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2015.09.002_bib0225","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2141.1997.942910.x","article-title":"Tobacco smoking and risk of haematological malignancies in adults: a case-control study","volume":"97","author":"Pasqualetti","year":"1997","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"7007","key":"10.1016\/j.leukres.2015.09.002_bib0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.leukres.2015.09.002_bib0240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-kappaB linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.leukres.2015.09.002_bib0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/07853890903405753","article-title":"Molecular pathways and targets in cancer-related inflammation","volume":"42","author":"Mantovani","year":"2010","journal-title":"Ann. Med."},{"issue":"9","key":"10.1016\/j.leukres.2015.09.002_bib0250","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/eji.201141727","article-title":"Monocytes link atherosclerosis and cancer","volume":"41","author":"Pittet","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2015.09.002_bib0255","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/0008-5472.CAN-04-2339","article-title":"Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression","volume":"65","author":"Komura","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.leukres.2015.09.002_bib0260","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1007\/s13277-014-1968-z","article-title":"Nicotine upregulates microRNA-21 and promotes TGF-\u03b2-dependent epithelial-mesenchymal transition of esophageal cancer cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"25","key":"10.1016\/j.leukres.2015.09.002_bib0265","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1182\/blood-2011-04-348755","article-title":"Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study","volume":"118","author":"Frederiksen","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2015.09.002_bib0270","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.leukres.2014.07.006","article-title":"The platelet-cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?","volume":"38","author":"Hasselbalch","year":"2014","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.leukres.2015.09.002_bib0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.leukres.2015.09.002_bib0280","first-page":"111","article-title":"The JAK2(V617F) tyrosine kinase mutation in blood donors with upper-limit haematocrit levels","volume":"7","author":"Tagariello","year":"2009","journal-title":"Blood Transfus."},{"key":"10.1016\/j.leukres.2015.09.002_bib0285","first-page":"7415","article-title":"Increased cell division as a cause of human cancer","volume":"50","author":"Preston-Martin","year":"1990","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1586\/17474086.2013.876356","article-title":"Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms","volume":"7","author":"Hasselbalch","year":"2014","journal-title":"Expert. Rev. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2015.09.002_bib0295","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/cyto.2002.1994","article-title":"Abnormal production of interleukin (IL)-11 and IL-8 in polycythaemia vera","volume":"20","author":"Hermouet","year":"2002","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0300","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood-2003-12-4415","article-title":"IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis","volume":"105","author":"Emadi","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2015.09.002_bib0305","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2015.09.002_bib0310","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2015.09.002_bib0315","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3324\/haematol.2012.071183","article-title":"Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasms","volume":"98","author":"Wehrle","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20110540","article-title":"A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2","volume":"209","author":"Kaufmann","year":"2012","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.leukres.2015.09.002_bib0325","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood-2013-10-534222","article-title":"RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling","volume":"123","author":"Kapralova","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0330","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.leukres.2013.07.002","article-title":"A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?","volume":"38","author":"Hasselbalch","year":"2014","journal-title":"Leuk. Res."},{"issue":"16","key":"10.1016\/j.leukres.2015.09.002_bib0335","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1158\/1078-0432.CCR-06-2898","article-title":"Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways","volume":"15;13","author":"Zhang","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.leukres.2015.09.002_bib0340","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/emboj.2012.125","article-title":"The updated biology of hypoxia-inducible factor","volume":"31","author":"Greer","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.leukres.2015.09.002_bib0345","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mrrev.2008.07.002","article-title":"Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms","volume":"681","author":"Zhang","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.leukres.2015.09.002_bib0350","unstructured":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens: Chemical Agents and Related Occupations. WHO International Agency for Research on Cancer 2012; 100F:401\u2013435."},{"key":"10.1016\/j.leukres.2015.09.002_bib0355","unstructured":"NTP. (National Toxicology Program). Report on Carcinogens, Twelfth Edition. Research Triangle Park. 2012; 195\u2013205."},{"key":"10.1016\/j.leukres.2015.09.002_bib0360","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/10408444.2011.560140","article-title":"Is exposure to formaldehyde in air causally associated with leukemia? \u2013A hypothesis-based weight-of-evidence analysis","volume":"41","author":"Rhomberg","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.leukres.2015.09.002_bib0365","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/1055-9965.EPI-09-0762","article-title":"Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells","volume":"19","author":"Zhang","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"9","key":"10.1016\/j.leukres.2015.09.002_bib0370","doi-asserted-by":"crossref","first-page":"e74974","DOI":"10.1371\/journal.pone.0074974","article-title":"Bone marrow injury induced via oxidative stress in mice by inhalation exposure to formaldehyde","volume":"11;8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2015.09.002_bib0375","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1182\/blood-2011-01-330050","article-title":"Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells","volume":"118","author":"Yahata","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0380","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","article-title":"Whole blood transcriptional profiling of interferon inducible genes identifies highly upregulated IFI27 in primary myelofibrosis","volume":"87","author":"Skov","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2015.09.002_bib0385","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.exphem.2012.05.011","article-title":"Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis","volume":"40","author":"Skov","year":"2012","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2015.09.002_bib0390","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.leukres.2012.07.009","article-title":"Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance","volume":"36","author":"Skov","year":"2012","journal-title":"Leuk. Res."},{"issue":"11","key":"10.1016\/j.leukres.2015.09.002_bib0395","doi-asserted-by":"crossref","first-page":"e112786","DOI":"10.1371\/journal.pone.0112786","article-title":"Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression","volume":"9","author":"Hasselbalch","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.leukres.2015.09.002_bib0400","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3324\/haematol.2011.055392","article-title":"The JAK2 46\/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?","volume":"96","author":"Hermouet","year":"2011","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.leukres.2015.09.002_bib0405","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.002_bib0410","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/01.CIR.0000127128.52679.E4","article-title":"Upregulation of the CD40\/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers","volume":"109","author":"Harding","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.leukres.2015.09.002_bib0415","first-page":"1779","article-title":"Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"98","author":"Gupta","year":"2006","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.leukres.2015.09.002_bib0420","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)64518-X","article-title":"Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept","volume":"157","author":"Zucker-Franklin","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0425","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0609.1983.tb00634.x","article-title":"Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases","volume":"30","author":"Tinggaard Pedersen","year":"1983","journal-title":"Scand. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0430","doi-asserted-by":"crossref","first-page":"e85567","DOI":"10.1371\/journal.pone.0085567","article-title":"Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation","volume":"9","author":"Hasselbalch","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.leukres.2015.09.002_bib0435","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/leu.2014.5","article-title":"Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis","volume":"28","author":"Tabarroki","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2015.09.002_bib0440","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1165\/rcmb.2007-0424OC","article-title":"Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease","volume":"39","author":"Suzuki","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.leukres.2015.09.002_bib0445","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.23632","article-title":"Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients","volume":"89","author":"Muendlein","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2015.09.002_bib0450","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1002\/ajh.23874","article-title":"Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease","volume":"90","author":"Muendlein","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2015.09.002_bib0455","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","article-title":"Autoimmunity and the risk of myeloproliferative neoplasms","volume":"95","author":"Kristinsson","year":"2010","journal-title":"Haematologica"},{"issue":"1\u20132","key":"10.1016\/j.leukres.2015.09.002_bib0460","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mrfmmm.2010.01.017","article-title":"Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population","volume":"690","author":"Ferguson","year":"2010","journal-title":"Mutat. Res."},{"issue":"8","key":"10.1016\/j.leukres.2015.09.002_bib0465","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.leukres.2015.09.002_bib0470","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1182\/blood-2007-06-095703","article-title":"Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders","volume":"111","author":"Pardanani","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0475","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1423-0410.2012.01644.x","article-title":"Characterization of blood donors with high haemoglobin concentration","volume":"104","author":"Magnussen","year":"2013","journal-title":"Vox Sang."},{"issue":"4","key":"10.1016\/j.leukres.2015.09.002_bib0480","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2005.039404","article-title":"Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis","volume":"65","author":"Larsson","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.leukres.2015.09.002_bib0485","first-page":"237","article-title":"A clinical review of recent findings in the epidemiology of inflammatory bowel disease","volume":"5","author":"Ponder","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.leukres.2015.09.002_bib0490","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jhep.2006.01.037","article-title":"Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway","volume":"45","author":"Di Bona","year":"2006","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.leukres.2015.09.002_bib0495","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2013a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2015.09.002_bib0500","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:28:48Z","timestamp":1567164528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615303738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0145212615303738"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.09.002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smoking as a contributing factor for development of polycythemia vera and related neoplasms","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}